Among patients with gynecologic cancer who died from COVID-19, 41.2 percent were Black<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
WEDNESDAY, Dec. 9, 2020 (HealthDay News) — Black gynecologic oncology patients with COVID-19 are more likely to require hospitalization and have a disproportionate rate of death, according to a study published online Dec. 9 in Cancer.<\/em><\/p>\n Olivia D. Lara, M.D., from New York University Langone Health in New York City, and colleagues abstracted data from gynecologic oncology patients with COVID-19 infection among eight New York City area hospital systems. COVID-19-related hospitalization and mortality were analyzed using a multivariable mixed-effects logistic regression model.<\/p>\n Overall, 34.7 and 65.3 percent of the 193 patients who had gynecologic cancer and COVID-19 were Black and non-Black, respectively. The researchers found that compared with non-Blacks, Black patients were more likely to require hospitalization (71.6 versus 46.0 percent). Overall, 41.2 percent of the 34 patients who died from COVID-19 were Black. Among those who were hospitalized, Black patients were significantly more likely than non-Black patients to have three or more comorbidities (81.1 versus 59.2 percent); to reside in Brooklyn (81.0 versus 44.4 percent); to live with family (69.4 versus 41.6 percent); and to have public insurance (79.6 versus 53.4 percent). Among patients younger than 65 years, Blacks were more likely to need hospitalization compared with non-Blacks in a multivariable analysis (odds ratio, 4.87).<\/p>\n “COVID-19 infection outcomes experienced by Black women highlight preexisting disparities and call for multifaceted attention to address these longstanding differences in health outcomes among patients with gynecologic cancer,” the authors write.<\/p>\n Several authors disclosed financial ties to the pharmaceutical industry.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n